Home Stock

Stock Research: Sanofi India

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sanofi India

NSI:SANOFI INE058A01010
28
  • Value
    28
  • Growth
    18
  • Safety
    Safety
    83
  • Combined
    30
  • Sentiment
    52
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sanofi India Limited manufactures and trades drugs and pharmaceuticals. The company focuses on therapeutic areas including diabetes (Lantus, Toustar), epilepsy (Frisium), cardiology (Cardace), allergy (Allegra, Avil), and pain care (Combiflam). It operates mainly in India, with a manufacturing facility in Goa and around 12 contract manufacturing organizations. In the last fiscal year, the company had a market cap of $1577 million, profits of $119 million, revenue of $235 million, and 991 employees.

more

ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock Sanofi India are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Sanofi India. The consolidated Sentiment Rank has a good rank of 52, which means that professional investors are more optimistic about the stock than for 52% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 83 or better than 83% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 28, meaning that the share price of Sanofi India is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 18. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Liquidity
Country France
Industry Pharmaceuticals
Size Small
Website sanofi.com
Index
Sanofi India stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
28 35 43 55
Growth
18 11 31 7
Safety
Safety
83 83 75 97
Sentiment
52 83 45 94
360° View
360° View
28 59 43 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
48 97 87 97
Opinions Change
50 50 50 50
Pro Holdings
n/a 50 25 92
Market Pulse
52 84 29 27
Sentiment
52 83 45 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
28 35 43 55
Growth
18 11 31 7
Safety Safety
83 83 75 97
Combined
30 23 47 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
60 36 29 39
Price vs. Earnings (P/E)
42 42 50 50
Price vs. Book (P/B)
28 10 14 43
Dividend Yield
1 67 76 82
Value
28 35 43 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
17 23 32 8
Profit Growth
28 12 59 32
Capital Growth
90 19 17 9
Stock Returns
8 47 83 25
Growth
18 11 31 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
85 84 82 92
Refinancing
42 32 32 48
Liquidity
96 90 88 92
Safety Safety
83 83 75 97

Similar Stocks

Discover high‑ranked alternatives to Sanofi India and broaden your portfolio horizons.

Rubis

PAR:RUI
Country: France
Industry: Gas Utilities
Size: Large
Full Stock Analysis

Ipsos

PAR:IPS
Country: France
Industry: Advertising
Size: Large
Full Stock Analysis

L.D.C.

PAR:LOUP
Country: France
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews